Pohl Boskamp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for POHL BOSKAMP, and when can generic versions of POHL BOSKAMP drugs launch?
POHL BOSKAMP has three approved drugs.
There are two US patents protecting POHL BOSKAMP drugs.
There are eighteen patent family members on POHL BOSKAMP drugs in nine countries.
Summary for Pohl Boskamp
| International Patents: | 18 |
| US Patents: | 2 |
| Tradenames: | 5 |
| Ingredients: | 1 |
| NDAs: | 3 |
Drugs and US Patents for Pohl Boskamp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pohl Boskamp | GONITRO | nitroglycerin | POWDER;SUBLINGUAL | 208424-001 | Jun 8, 2016 | DISCN | Yes | No | 9,101,592 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Pohl Boskamp | NITROLINGUAL PUMPSPRAY | nitroglycerin | SPRAY, METERED;SUBLINGUAL | 018705-002 | Jan 10, 1997 | AB | RX | Yes | Yes | 7,872,049 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Pohl Boskamp | NITROLINGUAL | nitroglycerin | AEROSOL;SUBLINGUAL | 018705-001 | Oct 31, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Pohl Boskamp | NITRONAL | nitroglycerin | INJECTABLE;INJECTION | 018672-001 | Aug 30, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Pohl Boskamp | NITRO IV | nitroglycerin | INJECTABLE;INJECTION | 018672-002 | Aug 30, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pohl Boskamp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pohl Boskamp | NITROLINGUAL PUMPSPRAY | nitroglycerin | SPRAY, METERED;SUBLINGUAL | 018705-002 | Jan 10, 1997 | 5,186,925 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for POHL BOSKAMP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Sublingual Spray | 400 mcg/spray, 4.9 g and 12 g bottles | ➤ Subscribe | 2012-08-23 |
| ➤ Subscribe | Sublingual Spray | 400 mcg/spray, 4.9 g and 12 g bottles | ➤ Subscribe | 2012-04-17 |
International Patents for Pohl Boskamp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2827714 | ⤷ Subscribe |
| Canada | 2718345 | ⤷ Subscribe |
| Australia | 2012219926 | ⤷ Subscribe |
| Poland | 2678006 | ⤷ Subscribe |
| European Patent Office | 2678000 | ⤷ Subscribe |
| Australia | 2009224968 | ⤷ Subscribe |
| European Patent Office | 2254552 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
